ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Nylidrin (United States and Canada: Not available): Drug information

Nylidrin (United States and Canada: Not available): Drug information
(For additional information see "Nylidrin (United States and Canada: Not available): Patient drug information")

For abbreviations, symbols, and age group definitions used in Lexicomp (show table)
Pharmacologic Category
  • Vasodilator, Peripheral
Dosing: Adult
Peripheral vascular disorders

Peripheral vascular disorders: Oral: 12 to 48 mg daily in 3 to 4 divided doses.

Organic mental disorders

Organic mental disorders: Oral: 12 to 24 mg daily in 3 to 4 divided doses.

Dosing: Kidney Impairment: Adult

No dosage adjustment provided in manufacturer’s labeling.

Dosing: Hepatic Impairment: Adult

No dosage adjustment provided in manufacturer’s labeling.

Dosing: Older Adult

Refer to adult dosing.

Adverse Reactions

The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined.

Cardiovascular: Orthostatic hypotension, palpitations

Central nervous system: Dizziness, nervousness

Gastrointestinal: Nausea, vomiting

Hypersensitivity: Hypersensitivity reaction

Neuromuscular & skeletal: Tremor, weakness

Contraindications

Acute myocardial infarction; paroxysmal tachycardia; progressive angina pectoris; thyrotoxicosis

Warnings/Precautions

Disease-related concerns:

• Cardiovascular disease: Use caution in patients with cardiovascular disease.

Other warnings/precautions:

• Appropriate use: Organic mental disorder: Diagnosis should be established and reversible and/or treatable conditions ruled out prior to initiating therapy; not indicated for use in patients experiencing normal aging symptoms or with presenile dementia.

Generic Equivalent Available: US

Yes

Use: Labeled Indications

Considered “possibly effective” for increasing blood supply to treat peripheral disease (arteriosclerosis obliterans, thromboangiitis obliterans, diabetic vascular disease, nocturnal leg cramps, Raynaud's disease, frost bite, ischemic ulcer, thrombophlebitis) and for mild-to-moderate symptoms associated with organic mental disorders

Metabolism/Transport Effects

None known.

Drug Interactions

There are no known significant interactions.

Pregnancy Considerations

Animal reproduction studies have not been conducted. Nylidrin has been evaluated for use as a tocolytic (Kurki, 1991).

Breastfeeding Considerations

It is not known if nylidrin is excreted in breast milk. Breast-feeding is not recommended by the manufacturer.

Mechanism of Action

Nylidrin is a peripheral vasodilator; this results from direct relaxation of vascular smooth muscle and beta-agonist action. Nylidrin does not appear to affect cutaneous blood flow; it reportedly increases blood flow to ischemic tissues with minimal blood pressure changes and increases cardiac output

Brand Names: International
International Brand Names by Country
For country code abbreviations (show table)

  • (DE) Germany: Dilatol;
  • (FI) Finland: Dilaver;
  • (IN) India: Arlidin;
  • (JP) Japan: Nyderal | Verina;
  • (MX) Mexico: Arlidin;
  • (TR) Turkey: Perdilat;
  • (TW) Taiwan: Lidrin | Nylatin | Nylidrin HCL
  1. Kurki T, Eronen M, Lumme R, et al, "A Randomized Double-Dummy Comparison Between Indomethacin and Nylidrin in Threatened Preterm Labor," Obstet Gynecol, 1991, 78(6):1093-7. [PubMed 1945214]
Topic 10176 Version 83.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟